<qa>  What was the positive control drug that subjects received?Subjects attended a two-session, randomized, double-blind, crossover qualification in which they received the positive control drug Marinol 30 mg and matching placebo 48 hours apart in a randomized fashion. To qualify, subjects must have discriminated between Marinol and placebo. 